Truist Securities Maintains Hold on Treace Medical Concepts, Lowers Price Target to $6

Benzinga · 10/14 14:31
Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price target from $7.5 to $6.